Bristol-Myers Sued Over Heart Damage In Hep C Drug Trial

Law360, New York (August 27, 2012, 6:08 PM EDT) -- A Texas woman who says she needs a heart transplant after taking an experimental hepatitis C drug developed by Bristol-Myers Squibb Co. sued the drugmaker on Friday, the same day the company announced it’s taking a $1.8 billion charge on the discontinued treatment.

Janet Schaefer Vella claims she started the medicine, known as BMS-986094, during a clinical trial in early July and after one week underwent a diagnostic test that indicated possible heart malfunction. Vella says she was told to keep taking the drug and had...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.